Featured Research

from universities, journals, and other organizations

Nearly 19 million cancer survivors in the U.S. by 2024, new report estimates

Date:
June 1, 2014
Source:
American Cancer Society
Summary:
The number of cancer survivors in the United States, currently estimated to be 14.5 million, will grow to almost 19 million by 2024, a new report says. The findings suggest that even though cancer incidence rates have been decreasing for ten years, the number of cancer survivors is growing. This is the result of increases in cancer diagnoses driven by the aging and growth of the population, as well as the fact that people are living longer with cancer because of earlier cancer detection and more effective treatments.

The number of cancer survivors in the United States, currently estimated to be 14.5 million, will grow to almost 19 million by 2024, according to an updated report by the American Cancer Society. The second edition of Cancer Treatment & Survivorship Facts & Figures, 2014-2015 and an accompanying journal article published in CA: A Cancer Journal for Clinicians find that even though cancer incidence rates have been decreasing for ten years, the number of cancer survivors is growing. This is the result of increases in cancer diagnoses driven by the aging and growth of the population, as well as the fact that people are living longer with cancer because of earlier cancer detection and more effective treatments.

The three most common cancers among males living with a history of cancer in 2014 are prostate (43%), colorectal (9%), and melanoma (8%). Among women in 2014, the three most common cancers are breast (41%), uterine (8%), and colorectal (8%). While lung cancer is the leading cause of cancer death and the second most commonly diagnosed cancer in both men and women, a low survival rate makes it the number eight cancer site represented among survivors. The distribution of prevalent cancers is expected to be largely unchanged in 2024.

Other selected findings:

  • The majority of cancer survivors (64%) were diagnosed five or more years previously, and 15% were diagnosed 20 or more years ago.
  • Nearly one-half of cancer survivors (46%) are aged 70 years or older, while one in 20 (5%) is under age 40.
  • The age distribution of cancer survivors varies substantially by cancer type. For example, the majority of prostate cancer survivors (62%) are aged 70 and older, whereas less than one-third (32%) of melanoma survivors are in this age group.
  • By January 1, 2024, it is estimated that the population of cancer survivors will increase to nearly 19 million individuals (9.3 million males and 9.6 million females).

In addition to prevalence estimates, the reports also include data on cancer treatment patterns, survival, and information on common short- and long-term effects of cancer and its treatment for eleven selected cancers. Cancer Treatment and Survivorship Facts & Figures also contains sections on the effects of cancer and its treatment, impairment-driven cancer rehabilitation, palliative care, long term survivorship, the benefits of healthy behaviors, and resources for cancer survivors from the American Cancer Society and other organizations.

"The growing number of cancer survivors in the U.S. makes it increasingly important to understand the unique medical and psychosocial needs of survivors," said Carol DeSantis, MPH, American Cancer Society epidemiologist and lead author of the reports. "Despite the fact that awareness of survivorship issues has increased, cancer survivors face numerous, important hurdles created by a fractured health care system, poor integration of survivorship care, and financial and other barriers to quality care, particularly among the medically underserved. An important first step in addressing these challenges is to identify 'best practices' for the delivery of quality post-treatment cancer care."

The report can be found online at: http://www.cancer.org/research/cancerfactsstatistics/survivor-facts-figures


Story Source:

The above story is based on materials provided by American Cancer Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Carol E. DeSantis, Chun Chieh Lin, Angela B. Mariotto, Rebecca L. Siegel, Kevin D. Stein, Joan L. Kramer, Rick Alteri, Anthony S. Robbins, Ahmedin Jemal. Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for Clinicians, 2014; DOI: 10.3322/caac.21235

Cite This Page:

American Cancer Society. "Nearly 19 million cancer survivors in the U.S. by 2024, new report estimates." ScienceDaily. ScienceDaily, 1 June 2014. <www.sciencedaily.com/releases/2014/06/140601114040.htm>.
American Cancer Society. (2014, June 1). Nearly 19 million cancer survivors in the U.S. by 2024, new report estimates. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/06/140601114040.htm
American Cancer Society. "Nearly 19 million cancer survivors in the U.S. by 2024, new report estimates." ScienceDaily. www.sciencedaily.com/releases/2014/06/140601114040.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins